Lipo-C (10 mL)
Lipo-C is a 10 mL solution with methionine 15 mg/mL, choline chloride 50 mg/mL, L-carnitine 50 mg/mL and dexpanthenol 5 mg/mL, a composition as given in product catalogues, without independent verification. The blend has not been studied in a randomised trial. The figures below are data from sources and not instructions for use.
Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-10-31
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer
How It Works
The four ingredients are an amino acid, nutrients and a coenzyme precursor, with roles in cell metabolism. These are biological roles of the ingredients and not an effect of the blend.
Quick Start
- Schedule in the sources: 1 mL, 1–2 times a week.
- Route: sources disagree. One says subcutaneous or intramuscular, and a compounding pharmacy sheet says intramuscular only.
- Human data for the blend: none.
Schedule from published sources: Lipo-C
Route: Subcutaneous or intramuscular · compounding pharmacy sheet: intramuscular only | Frequency: 1–2 times a week
| Week | Dose | Units (per injection) |
|---|---|---|
| Reported schedule | 1 mL | 1 mL, 1–2 times a week |
peptidedosingprotocols.com describes 1 mL, 1–2 times a week, subcutaneously or intramuscularly, and also mentions 0.5–1 mL and schedules of 2–3 times a week (accessed 31/10/2026). The same source says no randomised trial of a comparable injection has been published. peptidedosages.com has no Lipo-C page.
Related compounds
Reconstitution Steps
- No reconstitution is required.
Protocol Overview
- Different compositions circulate under the same name, so sources are not always comparable. The source of the schedule describes another composition, with six ingredients.
- There is no randomized trial of the injectable blend.
- We found no human study of the injected ingredients in this form.
Dosing Protocol
- Schedule: 1 mL, 1–2 times a week.
- Subcutaneous carnitine: we did not find a human study.
Storage Instructions
- No published stability data were found.
Important Notes
- The blend has not been approved by the FDA or the EMA and there is no approved schedule.
- The sources that give a schedule do not base it on a trial of the blend.
Potential Benefits & Side Effects
Potential Side Effects:
- The safety profile of the blend has not been studied in a trial.
⚠️ Serious Warnings & Long-Term Risks
The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.
The blend has not been studied
No randomised trial of a comparable injection has been published.
📄 peptidedosingprotocols.com: Lipo-CReferences
- peptidedosingprotocols.com: Lipo-C — Source for the schedule. The page gives a different composition with six ingredients, so it is not used for the composition. Accessed 31/10/2026.
View Source
External Sources & Regulatory Status
Regulatory Approvals
No FDA/EMA approval for the blend
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
Continue Your Research
Explore tools and guides related to this protocol.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →